Stockreport

Clinical Utility of ALK Fusion Detection by Liquid Biopsy

Agilent Technologies, Inc.  (A) 
Last agilent technologies, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.agilent.com
PDF Cell-free DNA NGS detects common and novel ALK fusions in the plasma of lung cancer patients SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) [Read more]